Guggenheim Names Top Biotech Stock Pick Following JNJ Latest Deal
In short
Guggenheim has identified its top biotechnology stock pick in the wake of the latest deal by Johnson & Johnson. Further details regarding the specific company selected and the terms of the transaction were not disclosed.
Key points
- Guggenheim has identified its top biotechnology stock pick in the wake of the latest deal…: Guggenheim has identified its top biotechnology stock pick in the wake of the latest deal by Johnson & Johnson.
- Further details regarding the specific company selected and the terms of the transaction…: Further details regarding the specific company selected and the terms of the transaction were not disclosed.